Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China

Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China

Objective: To evaluate the cost effectiveness of vedolizumab vs. infliximab in the treatment of anti-tumor necrosis factor-alpha (TNF-α)-naïve patients with moderate-to-severe active ulcerative colitis (UC) in China.Methods: The costs and effectiveness of vedolizumab and infliximab in the treatment...

Full description

Bibliographic Details
Main Authors: Ting Zhou, Yanan Sheng, Haijing Guan, Rui Meng, Zijing Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Public Health
Subjects:
ulcerative colitis
vedolizumab
infliximab
cost-effectiveness analysis
China
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.704889/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2021.704889/full

Similar Items